Loading
A phase 3 trial of Goserelin / leuprolide and Toremifene in Breast cancer, run by Peking Union Medical College Hospital, with a status the registry has not verified recently.
Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea is a phase 3 interventional study registered as NCT02132390 by Peking Union Medical College Hospital, with 300 participants planned, started 2014-05 and due to reach its primary completion in 2024-05. Interventions recorded: Goserelin, Toremifene. Conditions recorded: Breast Cancer, Chemotherapy Induced Amenorrhea, Ovarian Function Suppression.
Linked to the drug Toremifene because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Shares Toremifene and the tag pipeline.
Shares Toremifene, Breast cancer (all types) and the tag pipeline.
Shares Goserelin / leuprolide (ovarian function suppression), Breast cancer (all types) and the tag pipeline.
Shares Goserelin / leuprolide (ovarian function suppression) and the tag pipeline.
Shares Goserelin / leuprolide (ovarian function suppression) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.